Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo

Endocrinology

Volumn 145, Issue 9, 2004, Pages 4366-4374

  Cornish, Jillian ^a   Callon, Karen E ^a   Naot, Dorit ^a   Palmano, Kate P ^c   Banovic, Tatjana ^a   Bava, Usha ^a   Watson, Maureen ^a   Lin, Jian Ming ^a   Tong, P C ^a   Chen, Qi ^a   Chan, Vincent A ^a   Reid, Helen E ^a   Fazzalari, Nick ^d   Baker, Heather M ^b   Baker, Edward N ^b   Haggarty, Neill W ^c   Grey, Andrew B ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c FONTERRA RESEARCH CENTRE   (New Zealand)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN; OSTEOCLAST DIFFERENTIATION FACTOR; RECOMBINANT PROTEIN; THYMIDINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE CELL; BONE MARROW; CALVARIA; CARTILAGE CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL LINE; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; FETUS; FLUOROCHROME STAINING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RAT;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CARTILAGE; CATTLE; CELL DIFFERENTIATION; CELL DIVISION; CHONDROCYTES; CRICETINAE; HUMANS; KIDNEY; LACTOFERRIN; MALE; MICE; MILK; MILK, HUMAN; ORGAN CULTURE TECHNIQUES; OSTEOBLASTS; OSTEOCLASTS; RATS; SKULL;

EID: 4344694236     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1307     Document Type: Article

References (49)

1. Metz-Boutigue MH, Jolles J, Mazurier J, Schoentgen F, Legrand D, Spik G, Montreuil J, Jolies P 1984 Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem 145:659-676
2. Lonnerdal B, Iyer S 1995 Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15:93-110
3. Dinauer MC, Lekstrom-Himes JA, Dale DC 2000 Inherited neutrophil disorders: molecular basis and new therapies. Hematology (Am Soc Hematol Educ Program)1:303-318
4. Caccavo D, Sebastiani GD, Di Monaco C, Guido F, Galeazzi M, Ferri GM, Bonomo L, Afeltra A 1999 Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis. Int J Clin Lab Res 29:30-35
5. Weinberg ED 2001 Human lactoferrin: a novel therapeutic with broad spectrum potential. J Pharm Pharmacol 53:1303-1310
6. Bi BY, Lefebvre AM, Dus D, Spik G, Mazurier J 1997 Effect of lactoferrin on proliferation and differentiation of the Jurkat human lymphoblastic T cell line. Arch Immunol Ther Exp (Warsz) 45:315-320
7. Ward PP, Mendoza-Meneses M, Mulac-Jericevic B, Cunningham GA, Saucedo-Cardenas O, Teng CT, Conneely OM 1999 Restricted spatiotemporal expression of lactoferrin during murine embryonic development. Endocrinology 140:1852-1860
8. Sawatzki G, Rich IN 1989 Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells 15:371-385
9. Baveye S, Elass E, Fernig DG, Blanquart C, Mazurier J, Legrand D 2000 Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun 68:6519-6525
10. Guillen C, McInnes IB, Vaughan DM, Kommajosyula S, Van Berkel PH, Leung BP, Aguila A, Brock JH 2002 Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J Immunol 168:3950-3957
11. Kimber I, Cumberbatch M, Dearman RJ, Headon DR, Bhushan M, Griffiths CE 2002 Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem Cell Biol 80:103-107
12. Elass E, Masson M, Mazurier J, Legrand D 2002 Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun 70:1860-1866
13. Frydecka I, Zimecki M, Bocko D, Kosmaczewska A, Teodorowska R, Ciszak L, Kruzel M, Wlodarska-Polinsk J, Kuliczkowski K, Kornafel J 2002 Lactoferrin-induced up-regulation of zeta (ζ) chain expression in peripheral blood T lymphocytes from cervical cancer patients. Anticancer Res 22:1897-1901
14. Baveye S, Elass E, Mazurier J, Spik G, Legrand D 1999 Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 37:281-286
15. Cornish J, Callon KE, Lin CQ, Xiao CL, Mulvey TB, Cooper GJ, Reid IR 1999 Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol 277:E779-E783
16. Robey PG, Termine JD 1985 Human bone cells in vitro. Calcif Tissue Int 37:453-460
17. Naot D, Callon KE, Grey A, Cooper GJS, Reid IR, Cornish J 2001 A potential role for adrenomedullin as a local regulator of bone growth. Endocrinology 142:1849-1857
18. Cornish J, Callon KE, Gasser JA, Bava U, Gardiner EM, Coy DH, Cooper GJS, Reid IR 2000 Systemic administration of a novel octapeptide, amylin-(1-8), increases bone volume in male mice. Am J Physiol 279:E730-E735
19. Cornish J, Callon K, King A, Edgar S, Reid IR 1993 The effect of leukemia inhibitory factor on bone in vivo. Endocrinology 132:1359-1366
20. Palmano KP, Elgar DF 2002 Detection and quantitation of lactoferrin in bovine whey samples by reversed-phase high-performance liquid chromatography on polystyrene-divinylbenzene. J Chromatogr A 947:307-311
21. Baker EN, Rumball SV 1977 Crystallographic data for human lactoferrin. J Mol Biol 111:207-210
22. Stowell KM, Rado TA, Funk WD, Tweedie JW 1991 Expression of cloned human lactoferrin in baby-hamster kidney cells. Biochem J 276:349-355
23. Aisen P, Leibman A 1972 Lactoferrin and transferrin: a comparative study. Biochim Biophys Acta 257:314-323
24. Cornish J, Callon KE, Edgar SG, Reid IR 1997 Leukemia inhibitory factor is mitogenic to osteoblasts. Bone 21:243-247
25. Cornish J, Callon KE, Lin CQ, Xiao CL, Gamble GD, Cooper GJ, Reid IR 1999 Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts. J Bone Miner Res 14:1302-1309
26. Cornish J, Balchin LM, Callon KE, Grey AB, Cooper GJS, Reid IR 2000 Amylin and adrenomedullin - novel promoters of osteoblast survival from apoptosis. Bone 27:193
27. Lorget F, Clough J, Oliveira M, Daury MC, Sabokbar A, Offord E 2002 Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. Biochem Biophys Res Commun 296:261-266
28. Hangoc G, Falkenburg JH, Broxmeyer HE 1991 Influence of T-lymphocytes and lactoferrin on the survival-promoting effects of IL-1 and IL-6 on human bone marrow granulocyte-macrophage and erythroid progenitor cells. Exp Hematol 19:697-703
29. Cornish J, Callon KE, Reid IR 1996 Insulin increases histomorphometric indices of bone formation in vivo. Calcif Tissue Int 59:492-495
30. Cornish J, Callon KE, Nicholson GC, Reid IR 1997 Parathyroid hormone-related protein-(107-139) inhibits bone resorption in vivo. Endocrinology 138:1299-1304
31. Cornish J, Callon KE, Coy DH, Jiang NY, Xiao L, Cooper GJ, Reid IR 1997 Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. Am J Physiol 273:E1113-E1120
32. Cornish J, Callon KE, Cooper GJ, Reid IR 1995 Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun 207:133-139
33. Cornish J, Callon KE, Reid IR 1995 An in vivo model for the rapid assessment of the local effects of parathyroid hormone on bone histomorphometry. Bone 17(Suppl 4):S249-S254
34. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G 1999 Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946-1949
35. Marcelli C, Yates AJ, Mundy GR 1990 In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice. J Bone Miner Res 5:1087-1096
36. Mackie EJ, Trechsel U 1990 Stimulation of bone formation in vivo by transforming growth factor-β: remodeling of woven bone and lack of inhibition by indomethacin. Bone 11:295-300
37. Hutchens TW, Henry JF, Yip TT 1991 Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation. Proc Natl Acad Sci USA 88:2994-2998
38. Zimecki M, Dawiskiba J, Zawirska B, Krawczyk Z, Kruzel M 2003 Bovine lactoferrin decreases histopathological changes in the liver and regulates cytokine production by splenocytes of obstructive jaundiced rats. Inflamm Res 52:305-310
39. Wakabayashi H, Takakura N, Teraguchi S, Tamura Y 2003 Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans. Microbiol Immunol 47:37-43
40. Kumari J, Swain T, Sahoo PK 2003 Dietary bovine lactoferrin induces changes in immunity level and disease resistance in Asian catfish Clarias batrachus. Vet Immunol Immunopathol 94:1-9
41. Lau EMC, Woo J, Lam V, Hong A 2001 Milk supplementation of the diet of postmenopausal Chinese women on a low calcium intake retards bone loss. J Bone Miner Res 16:1704-1709
42. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ 1993 Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 328:460-464
43. Zimecki M, Wlaszczyk A, Zagulski T, Kubler A 1998 Lactoferrin lowers serum interleukin 6 and tumor necrosis factor α levels in mice subjected to surgery. Arch Immunol Ther Exp (Warsz) 46:97-104
44. Zimecki M, Miedzybrodzki R, Szymaniec S 1998 Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production. Arch Immunol Ther Exp (Warsz) 46:361-365
45. He S, McEuen AR, Blewett SA, Li P, Buckley MG, Leufkens P, Walls AF 2003 The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G. Biochem Pharmacol 65:1007-1015
46. 45a. Grey A, Banovic T, Zhu Q, Watson M, Callon K, Palmano K, Ross J, Naot D, Reid IR, Cornish J, The low density lipoprotein-receptor-related protein 1 (LRP1) is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol, in press
47. Suzuki YA, Shin K, Lonnerdal B 2001 Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry 40:15771-15779
48. Grey A, Banovic T, Callon K, Palmano K, Lin JM, Chan V, Bava U, Reid IR, Cornish J 2003 Lactoferrin, a potent anabolic factor in bone, signals through the low-density lipoprotein receptor-related protein (LRP) 1. Bone 32:S88-S89
49. Strickland DK, Gonias SL, Argraves WS 2002 Diverse roles for the LDL receptor family. Trends Endocrinol Metab 13:66-74